Clincosm LogoSign in Get a demo

Ovarian Cancer

Showing NaN - NaN of 94
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer Trial in Canada, United Kingdom, United States (SGI-110, Treatment of Choice (topotecan, pegylated liposomal

Completed
Has Results
  • Ovarian Cancer
  • Los Angeles, California
  • +23 more
Apr 30, 2021

Advanced Solid Tumors, Ovarian Cancer, Breast Cancer Trial in Canada, France, United States (SY-1365 (Part 1), Carboplatin,

Terminated
  • Advanced Solid Tumors
  • +2 more
  • SY-1365 (Part 1)
  • +5 more
  • Birmingham, Alabama
  • +19 more
Mar 5, 2021

Small-cell Lung Cancer, Soft Tissue Sarcoma, Triple-negative Breast Cancer Trial in Canada, United States (Tinostamustine

Recruiting
  • Small-cell Lung Cancer
  • +4 more
  • Tinostamustine (EDO-S101)
  • Los Angeles, California
  • +7 more
Dec 22, 2020

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Tumors Trial in Worldwide (EPO906 (Patupilone), doxorubicin)

Completed
  • Ovarian Cancer
  • +2 more
  • Anchorage, Alaska
  • +148 more
Dec 11, 2020

Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab soravtansine,

Completed
Has Results
  • Epithelial Ovarian Cancer
  • +3 more
  • Mirvetuximab soravtansine
  • +3 more
  • Birmingham, Alabama
  • +130 more
Sep 24, 2020

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in United Kingdom, United States (Ramucirumab)

Completed
Has Results
  • Ovarian Cancer
  • +2 more
  • Ramucirumab
  • Hollywood, Florida
  • +12 more
Sep 10, 2019

Endometrial Cancer, Ovarian Cancer, Cervical Cancer Trial in Chicago, Salt Lake City (AL3818)

Terminated
  • Endometrial Cancer
  • +2 more
  • Chicago, Illinois
  • +1 more
Jun 17, 2019

Ovarian Cancer Trial in Japan, United States (carboplatin, paclitaxel)

Completed
Has Results
  • Ovarian Cancer
  • Birmingham, Alabama
  • +150 more
May 23, 2019

Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in United States (enzastaurin HCl)

Completed
Has Results
  • Ovarian Cancer
  • Primary Peritoneal Cavity Cancer
  • enzastaurin hydrochloride
  • Los Angeles, California
  • +15 more
Mar 8, 2019

Ovarian Cancer Trial in United States (SC-003, SC-003 in combination with ABBV-181)

Terminated
  • Ovarian Cancer
  • SC-003
  • SC-003 in combination with ABBV-181
  • Fayetteville, Arkansas
  • +15 more
Jan 2, 2019

Ovarian Cancer Trial in Worldwide (Pimasertib once daily, Pimasertib , SAR245409 )

Completed
Has Results
  • Ovarian Cancer
  • Pimasertib once daily
  • +4 more
  • Augusta, Georgia
  • +33 more
Nov 26, 2018

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in United States (topotecan HCl)

Completed
Has Results
  • Fallopian Tube Cancer
  • +2 more
  • topotecan hydrochloride
  • Hartford, Connecticut
  • +77 more
Jun 27, 2018

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in United States (filgrastim, pegfilgrastim,

Completed
Has Results
  • Fallopian Tube Cancer
  • +2 more
  • filgrastim
  • +3 more
  • Burbank, California
  • +36 more
Jun 21, 2018

Ovarian Cancer Trial in Worldwide (ABT-888, pegylated liposomal doxorubicin, temozolomide)

Completed
  • Ovarian Cancer
  • Duarte, California
  • +31 more
Jun 1, 2018

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Italy, Russian Federation, United States

Completed
Has Results
  • Ovarian Cancer
  • +2 more
  • Scottsdale, Arizona
  • +7 more
Mar 17, 2018

Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Canada, United States (topotecan HCl)

Terminated
  • Ovarian Cancer
  • Primary Peritoneal Cavity Cancer
  • topotecan hydrochloride
  • Birmingham, Alabama
  • +73 more
Apr 11, 2018

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in United States (motesanib diphosphate)

Terminated
Has Results
  • Fallopian Tube Cancer
  • +2 more
  • motesanib diphosphate
  • Burbank, California
  • +18 more
Dec 12, 2017

Ovarian Cancer, Renal Cancer, NSCLC Trial in United States (Carfilzomib, Dexamethasone)

Completed
Has Results
  • Ovarian Cancer
  • +6 more
  • Scottsdale, Arizona
  • +6 more
Jul 14, 2017

Ovarian Cancer, Primary Peritoneal Cancer, Serous Carcinoma Cancer Trial in Canada, United States (ABT-888, Cyclophosphamide)

Completed
Has Results
  • Ovarian Cancer
  • +4 more
  • Davis, California
  • +9 more
Mar 16, 2017

Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cancer Trial in Worldwide (AMG 386, Paclitaxel, AMG 386 Placebo)

Terminated
  • Fallopian Tube Cancer
  • +2 more
  • AMG 386
  • +3 more
  • Birmingham, Alabama
  • +309 more
Feb 22, 2017

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in United States (docetaxel, vandetanib)

Completed
Has Results
  • Fallopian Tube Cancer
  • +2 more
  • Mobile, Alabama
  • +136 more
Oct 26, 2016

Ovarian Cancer Early Detection and Prevention

Unknown status
  • Cervical Cancer
  • +8 more
  • laboratory biomarker analysis
  • +2 more
  • Chicago, Illinois
    Robert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Sep 29, 2016

Ovarian Cancer Trial in Chicago (Dexamethasone, Placebo)

Completed
Has Results
  • Ovarian Cancer
  • Chicago, Illinois
    The University of Chicago
Jun 2, 2016

Ovarian Cancer Trial in Australia, New Zealand, United States (Carboplatin, Gemcitabine, BNC105P)

Withdrawn
  • Ovarian Cancer
  • Chicago, Illinois
  • +5 more
Dec 21, 2015

Ovarian Cancer, Peritoneal Cavity Cancer Trial in United States (carboplatin, pegylated liposomal doxorubicin HCl)

Completed
  • Ovarian Cancer
  • Peritoneal Cavity Cancer
  • Mobile, Alabama
  • +90 more
Oct 23, 2015